Société Sigilon Therapeutics, Inc.
Actions
SGTX
US82657L2060
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 62
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 60 | 14/08/18 | |
Director of Finance/CFO | 58 | 01/11/19 | |
Philip Johnson
PSD | President | 59 | 11/08/23 |
Bernd Kullmann
COO | Chief Operating Officer | - | - |
Qing Sarah Yuan
CTO | Chief Tech/Sci/R&D Officer | 53 | 07/03/22 |
Chief Tech/Sci/R&D Officer | 60 | 14/06/21 | |
Chief Administrative Officer | 52 | 01/01/19 | |
Michael Thompson
BRD | Director/Board Member | - | 11/08/23 |
Robert Windsor
IRC | Investor Relations Contact | - | 01/05/21 |
Chris Anderson
SEC | Corporate Secretary | - | 11/08/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 60 | 14/08/18 | |
Philip Johnson
PSD | President | 59 | 11/08/23 |
Gordon Brooks
BRD | Director/Board Member | - | 11/08/23 |
Michael Thompson
BRD | Director/Board Member | - | 11/08/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 502 084 | 2 294 190 ( 91,69 %) | 0 | 91,69 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+41,03 % | 50,93 Md | |
-0,45 % | 42,12 Md | |
+49,62 % | 42,05 Md | |
-7,20 % | 29,18 Md | |
+12,89 % | 26,02 Md | |
-21,94 % | 18,9 Md | |
+7,26 % | 13,21 Md | |
+24,38 % | 12,17 Md | |
+30,35 % | 12,16 Md |